RSV | For Healthcare Professionals | Respiratory Syncytial Virus | CDC - synagis adults rsv


What is SYNAGIS® (palivizumab)? synagis adults rsv

Aug 09, 2018 · Synagis (palivizumab) is a man-made antibody to respiratory syncytial virus (RSV). RSV can cause serious illness in children. Palivizumab helps keep RSV cells from multiplying in the body. Synagis is used to prevent serious lung disease caused by respiratory syncytial virus in premature infants, and infants born with certain lung disorders or heart disease.Drug class: immune globulins.

SYNAGIS is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children: born prematurely (at or before 35 weeks) and who are 6 months of age or less at the beginning of RSV season.

What is severe RSV disease? RSV is a common virus—one that can be very serious for high-risk babies. Respiratory syncytial (sin-SISH-Shull) virus, or RSV is a common virus that many parents may not have heard of. Like the flu, RSV is a seasonal virus that is easily spread.

Nov 06, 2018 · RSV usually causes mild, cold-like symptoms, but it can lead to serious illness, especially for infants and older adults. Wash your hands often to help protect yourself and others from RSV. Respiratory syncytial virus, or RSV, can cause severe lung infections, including bronchiolitis (infection of.